These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 35065733)
1. Papilledema due to Vaccine-Induced Thrombocytopenia. Qian J; Lutchman C; Margolin E Ophthalmology; 2022 Feb; 129(2):190. PubMed ID: 35065733 [No Abstract] [Full Text] [Related]
2. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban. Guetl K; Gary T; Raggam RB; Schmid J; Wölfler A; Brodmann M Lancet; 2021 Jun; 397(10293):e19. PubMed ID: 34126043 [No Abstract] [Full Text] [Related]
3. Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Gardellini A; Guidotti F; Maino E; Steffanoni S; Zancanella M; Turrini M Blood Cells Mol Dis; 2021 Dec; 92():102615. PubMed ID: 34653943 [No Abstract] [Full Text] [Related]
4. Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Marchandot B; Carmona A; Trimaille A; Curtiaud A; Morel O J Thromb Thrombolysis; 2021 Oct; 52(3):689-691. PubMed ID: 34129181 [No Abstract] [Full Text] [Related]
5. Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia. Chen VM; Curnow JL; Tran HA; Choi PY Med J Aust; 2021 Sep; 215(6):245-249.e1. PubMed ID: 34490632 [No Abstract] [Full Text] [Related]
6. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management. Alam W Sci Prog; 2021; 104(2):368504211025927. PubMed ID: 34120531 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Furie KL; Cushman M; Elkind MSV; Lyden PD; Saposnik G; Stroke; 2021 Jul; 52(7):2478-2482. PubMed ID: 33914590 [No Abstract] [Full Text] [Related]
9. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013 [TBL] [Abstract][Full Text] [Related]
10. Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia. Bersinger S; Lagarde K; Marlu R; Pernod G; Payen JF Crit Care Med; 2021 Sep; 49(9):e870-e873. PubMed ID: 34049307 [TBL] [Abstract][Full Text] [Related]
11. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia. Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525 [No Abstract] [Full Text] [Related]
13. The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia. Uzun G; Althaus K; Singh A; Möller P; Ziemann U; Mengel A; Rosenberger P; Guthoff M; Petzold GC; Müller J; Büchsel M; Feil K; Henkes H; Heyne N; Maschke M; Limpach C; Nagel S; Sachs UJ; Fend F; Bakchoul T Blood; 2021 Sep; 138(11):992-996. PubMed ID: 34166507 [No Abstract] [Full Text] [Related]
14. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Candelli M; Rossi E; Valletta F; De Stefano V; Franceschi F Br J Haematol; 2021 Aug; 194(3):547-549. PubMed ID: 33934330 [No Abstract] [Full Text] [Related]
15. Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination. Al-Ahmad M; Al Rasheed M; Shalaby N; Rodriguez-Bouza T; Altourah L Clin Appl Thromb Hemost; 2022; 28():10760296211073920. PubMed ID: 35108113 [No Abstract] [Full Text] [Related]
16. Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine. Sivaramakrishnan P; Mishra M BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354570 [TBL] [Abstract][Full Text] [Related]
17. Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Ikenberg B; Demleitner AF; Thiele T; Wiestler B; Götze K; Mößmer G; Lingor P Stroke Vasc Neurol; 2021 Dec; 6(4):668-670. PubMed ID: 34244448 [TBL] [Abstract][Full Text] [Related]
18. Cerebral Venous Sinus Thrombosis and Papilledema in Vaccine-Induced Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination. Donaldson L; Qian J; Lutchman C; AlShafai L; Margolin E J Neuroophthalmol; 2023 Mar; 43(1):e16-e18. PubMed ID: 36729051 [No Abstract] [Full Text] [Related]
19. Disc edema in one eye and central serous chorioretinopathy in the other eye shortly after AstraZeneca COVID-19 vaccination. Lee DY; Wu HJ; Cheng KC; Chang YC Kaohsiung J Med Sci; 2022 Mar; 38(3):283-285. PubMed ID: 34783448 [No Abstract] [Full Text] [Related]
20. Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombo- cytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study. Congiu T; Fanni D; Piras M; Gerosa C; Cau F; Barcellona D; D'Aloja E; Demontis R; Chighine A; Nioi M; Coni P; Ravarino A; Cerrone G; Aimola V; Botta C; Scano A; Orrù G; Coghe F; Van Eyken P; La Nasa G; Saba L; Suri JS; Faa G; Marongiu F Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):270-277. PubMed ID: 35049004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]